Beijing-Sana
The Chinese Pharmaceutical Industries Corporation "Sinovac" announced today that the authorities responsible for the pharmaceutical sector have given the green light on conditions for the use of a vaccine it developed against Corona called "Corona Vacc".
According to a Sinovac statement, which was carried by the French Press Agency, the approval of the use of the vaccine comes after several local and foreign tests of the vaccine in countries including Brazil and Turkey, explaining that "there is still a need to verify with an additional degree of the results of its effectiveness and safety."
And she stated that tests in Brazil showed that the vaccine is about 50 percent effective in preventing infection and by 80 percent in preventing infections from developing to levels that require medical intervention.
The "Corona Vacc" vaccine was used even before the announcement to vaccinate major groups that are more vulnerable to infection with the Coronavirus, but its approval today allows its use for the public.
The conditional approval contributes to the introduction of emergency drugs onto the market when clinical tests do not meet usual standards but indicate that the treatments will be effective.
The approval of the "Sinovac" vaccine comes weeks after the Chinese company, "Sinopharma" for the pharmaceutical industry, also gave a conditional green light to put its vaccine on the market.
